MedPath

Clinical study of modified Banxia Xiexin Decoction on improving urinary microalbuminuria in patients with diabetic nephropathy by regulating intestinal functio

Phase 1
Not yet recruiting
Conditions
diabetic nephropathy
Registration Number
ITMCTR2000003575
Lead Sponsor
Shanghai Sixth People's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

western medicine diagnostic criteria: according to Ada (2014) diagnostic criteria, diabetic nephropathy was definitely diagnosed as diabetes, GFR < 60ml / min / 1.73m2 or urinary albumin / creatinine ratio (ACR) was higher than 30mg / g for more than 3 months;

Exclusion Criteria

Uncooperative; patients with serious heart, liver, kidney, brain and other complications, or combined with other serious consumptive diseases, mental diseases; combined with other diseases affecting glucose and lipid metabolism, such as hyperthyroidism; patients with diabetic ketosis, ketoacidosis and infection in recent 1 month; patients with renal dysfunction caused by other reasons.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
urinary protein;
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath